Human monoclonal antibodies against CD20
View Patent ↗Isolated human monoclonal antibodies which bind to and inhibit human CD20, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
1. An isolated human monoclonal antibody which binds to human CD20, wherein said antibody is encoded by human heavy chain and human kappa light chain nucleic acids comprising the nucleotide sequences in their variable regions as set forth in SEQ ID NO:1 and SEQ ID NO:3, respectively.
2. An isolated human monoclonal antibody which binds to human CD20, wherein said antibody has human heavy chain and human kappa light chain variable regions comprising the amino acid sequences as set forth in SEQ ID NO:2 and SEQ ID NO:4, respectively.
3. A hybridoma which produces a human monoclonal antibody encoded by human IgG heavy chain and human kappa light chain nucleic acids comprising nucleotide sequences in their variable regions as set forth in SEQ ID NO:1 and SEQ ID NO:3, respectively.
4. A hybridoma which produces a human monoclonal having IgG heavy chain and kappa light chain variable regions which comprise the amino acid sequences as set forth in SEQ ID NO:2 and SEQ ID NO: 4, respectively.
5. A composition comprising a first human antibody and a second human antibody, both of which bind to human CD20, wherein the first antibody has human heavy chain and human kappa light chain variable regions comprising the amino acid sequences as set forth in SEQ ID NO:2 and SEQ ID NO:4, respectively, and wherein the second antibody has human heavy chain and human kappa light chain variable regions comprising the amino acid sequences as set forth in SEQ ID NO:10 and SEQ ID NO:12, respectively.